Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jul 2026 for Angiodynamics INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Lorinda Burgess: trading record in brief
Lorinda Burgess, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Angiodynamics Inc and Stepan Co. Over a trading history stretching from 27 April 2021 to 15 July 2026, the count stands at 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 22 July 2026 with a share grant in Angiodynamics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lorinda Burgess
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
11,887 shares0Common StockSEC:0001140361-26-029337:0
17,675 shares0Common StockSEC:0001140361-25-026459:0
20,541 shares0Common StockSEC:0001140361-24-033630:0
17,041 shares0Common StockSEC:0001140361-23-035701:0
1,325 shares@ US$94.32100.0% of flowCommon StockSEC:0001127602-23-013618:0
1,249 shares0Common StockSEC:0001127602-22-012611:0
6 of 6 declarations
